HPR59 Targeted and Immunotherapies for Cancer - Reimbursement and Expenditure in a Single-Payer Healthcare System in Bulgaria
| Autor: | Encheva-Malinova, M, Djambazov, S, Slavchev, G, Koleva-Kolarova, R |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S477-S477 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect